NASDAQ:REGN
Regeneron Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.regeneron.comipo date
Apr 02, 1991
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein oc...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus